though this in itself does not justify the extrapolation to cause and effect. Secondly, the study quoted did not take into account changes in glomerular filtration rate since GFR was not measured. Where accurate information regarding renal function is required, serum creatinine concentrations are not acceptable. A recent study of our own" highlighted the problem of elevated PTH in elderly subjects and indicated that this occurred almost exclusively in patients with a GFR below 50 mL/min as measured by SlCr_ EDTA clearance. The importance of correct assessment of GFR is emphasized by the observation in our study that 23 of the patients who had a 'normal' serum creatinine (< 120 ILmol/L) actually had a reduced GFR (< 80 mL/min). If the same discrepancy was present in Professor Swaminathan's study, it could well invalidate the 'correction' applied to his PTH/age correlation.
Thirdly, the statement that PTH increased by O' 26 pmol/L per decade is not supported by the data. Though Professor Swaminathan's paper did not provide the basic correlation data, it is easy to see that essentially two distinct populations were studied. Approximately, half the patients were over 60 years old, while only nine were in the 40-60 group. The statistical information given on the 19-40 age group (22' I ±O'4 years) indicates that around 90% of the group were aged 23 or less. It is not uncommon in regression analysis that two widely separated groups will provide a statistical correlation. The suggestion that there is a trend between the groups is untenable.
It is my belief that hyperparathyroidism is not an inescapable consequence of old age but has a cause, whether it be calcium/vitamin D deficiency or reduced renal function. In the case of renal impairment, hyperparathyroidism probably compensates for reduced renal 1,25-(OHh vitamin D synthesis." While an increase in circulating PTH is not the main factor responsible for bone mineral loss in the elderly, it is undesirable that there should be a situation causing increased bone turnover in people who are in negative calcium balance. It is better to identify the problem and treat it, rather than regard it as just another inconvenience of growing old. There is no reliable evidence to support the suggestion that hyperparathyroidism in the elderly is a consequence of old age and old age alone.
J S WOODHEAD Author's reply
There are three questions raised in the discussion about parathyroid hormone and age.
(1) Does parathyroid hormone increase with age? If I interpret Dr Woodhead's letter correctly he agrees that PTH increases with age. In the article by Dr Wood! it was stated that there is no difference in PTH in ambulatory elderly.
(2) What is the mechanism of the age-related increase in PTH? Dr Woodhead believes that it is due to a reduction in GFR. I believe that there is enough evidence to suggest that serum PTH increases independent of the effect of GFR. He correctly points out that we did not measure GFR in our study and we have used serum {3-2-microglobulin and plasma creatinine as measures of GFR. However, Sherman et 0[. 2 have measured creatinine clearance and showed that the increase in PTH with age is independent of the effect of GFR. As GFR declines with age one approach to dissect out the contribution of age and GFR to serum PTH is to use statistics, i.e. multiple regression analysis. However, statistical association does not imply cause and effect. In their recent paper! Dr Woodhead found that PTH was higher in subjects with GFR below 50 mL/min. However, it is not stated whether there was any difference in age between those with GFR < 50 mL/min and those with GFR > 50 mL/min.
In his letter Dr Woodhead also states that serum creatinine was normal « 120 ILmol/L) in those with reduced GFR (< 80 mL/min). However, it is well documented that plasma creatinine rises with age 4 • S and using a reference range determined in younger populations may not be valid.
(3) Is PTH increased in patients with hip fracture? We have shown that the bone density but not PTH6 is lower in patients with hip fracture. In fact our study shows that ionized calcium was slightly but significantly lower in hip fracture patients. Thus the PTH levels would be expected to be higher than controls. One interpretation of this data would be to say that PTH levels were lower than expected. 3 Gunn and Wallace's correlation between intact PTH and age may indicate either an altered PTH response, or that a structurally altered PTH molecule is present, or as suggested by Firek and coworkers," that control of parathyroid secretion may be the underlying fault.
None of the groups working on this topic have stated a prevalence for FBH in the general population. The prevalence of the disease will decide the positive predictive value of the tests advocated by Gunn and Wallace. Most of the data in the literature stems from three groups,2,6.7 presumably in referral centres, who have studied approximately 200 subjects from 50 families over a period of 15 years. Gunn and Wallace suggest that the prevalence of FBH is high (around one in 20 hypercalcaemic persons in their population). Their prevalence data is based on a mixed group of individuals and family members. Even with this (relatively) high prevalence a patient with a fasting urine calcium excretion of greater than 22 J.IlIlol/L would have only a 38% chance of having FBH. Until the prevalence in the general population has been determined and a definitive test has been found, accurate diagnosis of FBH will not be possible. For this reason Heath has suggested a systematic approach to the evaluation of hyperglycaernia.! Law and Heath stated that the key element in diagnosing FBH is a high index of suspicion.? Do Gunn and Wallace feel confident that the tests they studied will satisfy the criteria for acceptance as useful diagnostic tests? Should the assessment of patients with suspected primary
